Dr. Ian C. Carmody, MD

Dr. Carmody practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Dr. Carmody's NPI, 1932166824, was assigned on April 26, 2006. Dr. Carmody graduated from University of Toronto Faculty of Medicine in 1992. Dr. Carmody's Louisiana license number on file is MD200491.

Dr. Carmody's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Carmody's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. The medical group on file is Ochsner Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carmody practices. Vendor and product names are available with a free account.

Surgery is Dr. Carmody's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Carmody is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Carmody's licenses on file in 3 states: Louisiana, California and Alabama.

Dmand AI lists abdominal adhesion surgery and kidney transplant among the conditions Dr. Carmody treats.

CMS data shows 38 Medicare services from Dr. Carmody across 2 procedure codes in 2024, all of them office visits, for 43 Medicare patients. Medicare paid $2,304 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 43 Medicare patients who saw Dr. Carmody in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 6.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carmody's median patient age at 61, with 49% women.

In 2024, Dr. Carmody wrote 204 Medicare Part D claims for 35 patients. 82% of them were for generic drugs. CMS names the drug for 59 of them, across 4 drugs with 11 or more claims each, at $1,674 in total drug cost. In 2023, CMS named 85 claims across 6 drugs.

Dr. Carmody accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Carmody, published from 2013 to 2021. 2015 was the busiest year, with 4. The most frequent topics are Liver Transplantation, Tissue Donors and Graft Survival. Dr. Carmody has published most often in Ochsner J. Dr. Carmody's most frequent co-authors are Humberto Elias Bohorquez, MD, David S. Bruce, M and George E. Loss, MD.

Dmand AI links Dr. Carmody to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms.

CMS Open Payments shows 14 general payments to Dr. Carmody from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 52% of the total. OrganOx Ltd paid the most, $634.

Dmand AI lists 2 awards for Dr. Carmody, most recently CMS Stage 1 EHR in 2013.

Dr. Carmody graduated from University of Toronto Faculty of Medicine in 1992. Dr. Carmody is a member of ACS.

Dr. Carmody is in network with 14 carriers, including United Healthcare, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.